191 related articles for article (PubMed ID: 26159838)
1. Controlled release formulations of risperidone antipsychotic drug in novel aliphatic polyester carriers: Data analysis and modelling.
Siafaka PI; Barmpalexis P; Lazaridou M; Papageorgiou GZ; Koutris E; Karavas E; Kostoglou M; Bikiaris DN
Eur J Pharm Biopharm; 2015 Aug; 94():473-84. PubMed ID: 26159838
[TBL] [Abstract][Full Text] [Related]
2. Novel electrospun nanofibrous matrices prepared from poly(lactic acid)/poly(butylene adipate) blends for controlled release formulations of an anti-rheumatoid agent.
Siafaka PI; Barmbalexis P; Bikiaris DN
Eur J Pharm Sci; 2016 Jun; 88():12-25. PubMed ID: 27039136
[TBL] [Abstract][Full Text] [Related]
3. Preparation of New Risperidone Depot Microspheres Based on Novel Biocompatible Poly(Alkylene Adipate) Polyesters as Long-Acting Injectable Formulations.
Nanaki S; Barmpalexis P; Papakonstantinou Z; Christodoulou E; Kostoglou M; Bikiaris DN
J Pharm Sci; 2018 Nov; 107(11):2891-2901. PubMed ID: 30096352
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of nanoparticles containing an atypical antipsychotic agent.
Singh S; Muthu MS
Nanomedicine (Lond); 2007 Apr; 2(2):233-40. PubMed ID: 17716123
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of various drug carriers in controlled release formulations of raloxifene HCl prepared by melt mixing.
Bikiaris D; Karavelidis V; Karavas E
Curr Drug Deliv; 2009 Oct; 6(5):425-36. PubMed ID: 19751201
[TBL] [Abstract][Full Text] [Related]
6. A systematic study of captopril-loaded polyester fiber mats prepared by electrospinning.
Zhang H; Lou S; Williams GR; Branford-White C; Nie H; Quan J; Zhu LM
Int J Pharm; 2012 Dec; 439(1-2):100-8. PubMed ID: 23043960
[TBL] [Abstract][Full Text] [Related]
7. Risperidone Controlled Release Microspheres Based on Poly(Lactic Acid)-Poly(Propylene Adipate) Novel Polymer Blends Appropriate for Long Acting Injectable Formulations.
Nanaki S; Barmpalexis P; Iatrou A; Christodoulou E; Kostoglou M; Bikiaris DN
Pharmaceutics; 2018 Aug; 10(3):. PubMed ID: 30104505
[TBL] [Abstract][Full Text] [Related]
8. Polyester-based microparticles of different hydrophobicity: the patterns of lipophilic drug entrapment and release.
Korzhikov V; Averianov I; Litvinchuk E; Tennikova TB
J Microencapsul; 2016 May; 33(3):199-208. PubMed ID: 26888064
[TBL] [Abstract][Full Text] [Related]
9. Blends of poly-(epsilon-caprolactone) and polysaccharides in tissue engineering applications.
Ciardelli G; Chiono V; Vozzi G; Pracella M; Ahluwalia A; Barbani N; Cristallini C; Giusti P
Biomacromolecules; 2005; 6(4):1961-76. PubMed ID: 16004434
[TBL] [Abstract][Full Text] [Related]
10. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complex formation between alpha-cyclodextrin and biodegradable aliphatic polyesters.
Shin KM; Dong T; He Y; Taguchi Y; Oishi A; Nishida H; Inoue Y
Macromol Biosci; 2004 Dec; 4(12):1075-83. PubMed ID: 15586392
[TBL] [Abstract][Full Text] [Related]
12. Poly(ε-caprolactone), Eudragit® RS 100 and poly(ε-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz.
Seremeta KP; Chiappetta DA; Sosnik A
Colloids Surf B Biointerfaces; 2013 Feb; 102():441-9. PubMed ID: 23010128
[TBL] [Abstract][Full Text] [Related]
13. Linear-dendrimer type methoxy-poly (ethylene glycol)-b-poly (ε-caprolactone) copolymer micelles for the delivery of curcumin.
Song Z; Zhu W; Song J; Wei P; Yang F; Liu N; Feng R
Drug Deliv; 2015 Jan; 22(1):58-68. PubMed ID: 24725028
[TBL] [Abstract][Full Text] [Related]
14. Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation.
Muthu MS; Singh S
Nanomedicine (Lond); 2008 Jun; 3(3):305-19. PubMed ID: 18510426
[TBL] [Abstract][Full Text] [Related]
15. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
16. Complexation of risperidone with a taste-masking resin: novel application of near infra-red and chemical imaging to evaluate complexes.
Tawakkul MA; Shah RB; Zidan A; Sayeed VA; Khan MA
Pharm Dev Technol; 2009; 14(4):409-21. PubMed ID: 19630698
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterizations, in vitro and in vivo evaluation of Etoricoxib-loaded Poly (Caprolactone) microparticles--a potential Intra-articular drug delivery system for the treatment of Osteoarthritis.
Arunkumar P; Indulekha S; Vijayalakshmi S; Srivastava R
J Biomater Sci Polym Ed; 2016; 27(4):303-16. PubMed ID: 26689653
[TBL] [Abstract][Full Text] [Related]
18. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
Yang Y; Hua C; Dong CM
Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable radiopaque iodinated poly(ester urethane)s containing poly(ε-caprolactone) blocks: synthesis, characterization, and biocompatibility.
Sang L; Wei Z; Liu K; Wang X; Song K; Wang H; Qi M
J Biomed Mater Res A; 2014 Apr; 102(4):1121-30. PubMed ID: 23640806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
